medigraphic.com
Instituto Nacional de Salud Pública

2024, Número 3

<< Anterior Siguiente >>

salud publica mex 2024; 66 (3)


Asociación de factores sociodemográficos y síndrome metabólico en adultos mayores mexicanos

González-Rocha A, Ortiz-Rodríguez MA, Salazar-Torres BL, Muñoz-Aguirre P, Armenta-Girado BI, Campos-Nonato I, Barquera S, Denova-Gutiérrez E

Idioma: Español
Referencias bibliográficas: 31
Paginas: 267-276
Archivo PDF: 304.42 Kb.


RESUMEN

Objetivo. Estimar la prevalencia del síndrome metabólico (SMet) y su asociación con factores sociodemográficos en adultos mayores (AM) mexicanos. Material y métodos.Se analizaron datos de la Encuesta Nacional de Salud y Nutrición 2016; se incluyó información de 804 participantes ≥60 años. Se analizó información sobre sexo, edad, índice de masa corporal, escolaridad, origen étnico, tabaquismo, región geográfica, nivel socioeconómico y consumo de alcohol. Para el SMet, se utilizó la definición armonizada de la Federación Internacional de Diabetes. Se utilizaron modelos de regresión logística múltiple para evaluar la razón de momios (RM) e intervalos de confianza de 95% (IC95%) entre los factores sociodemográficos y el SMet. Resultados. La prevalencia del SMet fue de 77.4% (71.8% en hombres y 83.7% en mujeres). Los AM presentaron mayores momios de MetS cuando viven con sobrepeso, con obesidad, y los que tienen más años de escolaridad. Conclusión. La prevalencia de SMet en AM mexicanos es alta. Las mujeres, los fumadores y quienes viven con sobrepeso u obesidad presentan un mayor riesgo de padecer este síndrome. Este estudio es una visión panorámica de la necesidad de políticas para reducir la obesidad y otras enfermedades crónicas en esta población.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ju SY, Lee JY, Kim DH. Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: A metaanalysis of prospective cohort studies. Medicine (Baltimore). 2017;96(45): e8491. https://doi.org/10.1097/MD.0000000000008491

  2. Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: The Cardiovascular Health Study. Diabetes Care. 2005;28(4):882-7. https://doi.org/10.2337/diacare.28.4.882

  3. Dominguez LJ, Barbagallo M. The biology of the metabolic syndrome and aging. Curr Opin Clin Nutr Metab Care. 2016;19(1):5-11. https://doi.org/10.1097/MCO.0000000000000243

  4. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544. https://doi.org/10.1016/S0140-6736(16)31012-1

  5. Parra-Rodríguez L, González-Meljem JM, Gómez-Dantés H, Gutiérrez-Robledo LM, López-Ortega M, García-Peña C, et al. The Burden of Disease in Mexican Older Adults: premature mortality challenging a limitedresource health system. J Aging Health. 2020;32(7-8):543-53. https://doi.org/10.1177/0898264319836514

  6. Ortiz-Rodríguez MA, Yáñez-Velasco L, Carnevale A, Romero-Hidalgo S, Bernal D, Aguilar-Salinas C, et al. Prevalence of metabolic syndrome among elderly Mexicans. Arch Gerontol Geriatr. 2017;73:288-93. https://doi.org/10.1016/j.archger.2017.09.001

  7. Salas R, Bibiloni M del M, Ramos E, Villareal JZ, Pons A, Tur J, et al. Metabolic syndrome prevalence among Northern Mexican adult population. PLoS ONE. 2014;9(8):e105581. https://doi.org/10.1371/journal.pone.0105581

  8. Alberti KGMM, Zimmet P. The metabolic syndrome: Time to reflect. Curr Diab Rep. 2006;6(4):259-61. https://doi.org/10.1007/s11892-006-0057-0

  9. Merchant RA, Chan YH, Lim JY, Morley JE. Prevalence of metabolic syndrome and association with grip strength in older adults: findings from the HOPE Study. Diabetes Metab Syndr Obes Targets Ther. 2020;13:2677-86. https://doi.org/10.2147/DMSO.S260544

  10. Nishikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K. Metabolic syndrome and sarcopenia. Nutrients. 2021;13(10):3519. https://doi.org/10.3390/nu13103519

  11. Su YH, Chang YM, Kung CY, Sung CK, Foo WS, Wu MH, et al. A study of correlations between metabolic syndrome factors and osteosarcopenic adiposity. BMC Endocr Disord. 2021;21(1). https://doi.org/10.1186/s12902-021-00880-w

  12. Liaw FY, Kao TW, Wu LW, Wang CC, Yang HF, Peng TC, et al. Components of metabolic syndrome and the risk of disability among the elderly population. Sci Rep. 2016;6(1). https://doi.org/10.1038/srep22750

  13. Tsai CK, Kao TW, Lee JT, Wu CJ, Hueng DY, Liang CS, et al. Increased risk of cognitive impairment in patients with components of metabolic syndrome. Medicine (Baltimore). 2016;95(36):e4791. https://doi.org/10.1097/MD.0000000000004791

  14. Terschüren C, Damerau L, Petersen EL, Harth V, Agustin M, Zyriax BC. Association of dietary pattern, lifestyle and chronotype with metabolic syndrome in elderly-lessons from the population-based Hamburg City health study. Int J Environ Res Public Health. 2022;19(1):377. https://doi.org/10.3390/ijerph19010377

  15. Papaioannou KG, Kadi F, Nilsson A. Benefits of fruit and vegetable consumption on prevalence of metabolic syndrome are independent of physical activity behaviors in older adults. Nutrients. 2022;14(2):263. https://doi.org/10.3390/nu14020263

  16. Li Y, Zhao L, Yu D, Wang Z, Ding G. Metabolic syndrome prevalence and its risk factors among adults in China: A nationally representative crosssectional study. PLoS ONE. 2018;13(6):e0199293. https://doi.org/10.1371/journal.pone.0199293

  17. Barranco-Ruiz Y, Villa-González E, Venegas-Sanabria LC, Chavarro-Carvajal DA, Cano-Gutiérrez CA, Izquierdo M, et al. Metabolic syndrome and its associated factors in older adults: a secondary analysis of SABE Colombia in 2015. Metab Syndr Relat Disord. 2020;18(8):389-98. https://doi.org/10.1089/met.2019.0066

  18. De Oliveira-Costa AC, De Oliveira-Duarte YA, Bof de Andrade F. Síndrome metabólica: inatividade física e desigualdades socioeconômicas entre idosos brasileiros não institucionalizados. Rev Bras Epidemiol. 2020;23. https://doi.org/10.1590/1980-549720200046

  19. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Gómez-Humarán IM, Gaona-Pineda EB, Gómez-Acosta LM, et al. Diseño metodológico de la Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Salud Publica Mex. 2017;59(3):299. https://doi.org/10.21149/8593

  20. Hernández-Alcaraz C, Shamah-Levy T, Romero-Martínez M, Sepúlveda-Amor J, Aguilar-Salinas CA, Rivera-Dommarco JA, et al. Submuestra para el análisis de enfermedades crónicas con biomarcadores, Encuesta Nacional de Salud y Nutrición 2016. Salud Publica Mex. 2020;62(5):504-10. https://doi.org/10.21149/11306

  21. Howe LD, Galobardes B, Matijasevich A, Gordon D, Johnston D, Onwujekwe O, et al. Measuring socio-economic position for epidemiological studies in low- and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol. 2012;41(3):871-86. https://doi.org/10.1093/ije/dys037

  22. Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Medina C, Barquera S. Hipertensión arterial en adultos mexicanos: prevalencia, diagnóstico y tipo de tratamiento. Ensanut MC 2016. Salud Publica Mex. 2018;60(3):233-43. https://doi.org/10.21149/8813

  23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. https://doi.org/10.1093/clinchem/18.6.499

  24. Hernández-Alcaraz C, Aguilar-Salinas CA, Mendoza-Herrera K, Pedroza-Tobías A, Villalpando S, Shamah-Levy T, et al. Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012. Salud Publica Mex. 2020;62(2):137-46. https://doi.org/10.21149/10520

  25. Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, Aguilar-Salinas CA, López-Olmedo N, De la Cruz-Góngora V, et al. Prevalencia de diabetes y descontrol glucémico en México: resultados de la Ensanut 2016. Salud Publica Mex. 2019;62(1):50-9. https://doi.org/10.21149/10752

  26. Kıskaç M, Soysal P, Smith L, Capar E, Zorlu M. What is the optimal body mass index range for older adults? Ann Geriatr Med Res. 2022;26(1):49-57. https://doi.org/10.4235/agmr.22.0012

  27. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-45. https://doi.org/10.1161/CIRCULATIONAHA.109.192644

  28. Alemán-Mateo H, López-Teros MT, Urquidez-Romero R, Huesca L. Prevalence of metabolic syndrome and its determinants in older Mexican non-diabetic adults. Nutr Hosp. 2018;35(2):294-304. https://doi.org/10.20960/nh.1518

  29. Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol Res. 2017;120:34-42. https://doi.org/10.1016/j.phrs.2017.03.008

  30. Gallardo-Alfaro L, Bibiloni M del M, Mascaró CM, Montemayor S, Ruiz-Canela M, Salas-Salvador J, et al. Leisure-time physical activity, sedentary behaviour and diet quality are associated with metabolic syndrome severity: The PREDIMED-Plus Study. Nutrients. 2020;12(4):1013. https://doi.org/10.3390/nu12041013

  31. Bechtold M, Palmer J, Valtos J, Lasiello C, Sowers J. Metabolic syndrome in the elderly. Curr Diab Rep. 2006;6(1):64-71. https://doi.org/10.1007/s11892-006-0054-3




2020     |     www.medigraphic.com